Prestige Consumer Healthcare (PBH) Retained Earnings (2011 - 2025)
Prestige Consumer Healthcare's (PBH) quarterly Retained Earnings came in at $1.7 billion in Q4 2025, up 12.39% year-on-year from $1.5 billion in Q4 2024, and up 2.84% quarter-over-quarter from $1.6 billion in Q3 2025.
Prestige Consumer Healthcare (PBH) Retained Earnings (2011 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Retained Earnings history runs 15 years deep, the most recent figure standing at $1.7 billion for Q4 2025.
- On a quarterly basis, Retained Earnings rose 12.39% year-over-year to $1.7 billion in Q4 2025; TTM through Dec 2025 was $1.7 billion, a 12.39% increase from a year earlier, with the FY2025 full-year figure at $1.6 billion, up 16.0% from the prior year.
- Retained Earnings rose to $1.7 billion in Q4 2025 per PBH's latest filing, from $1.6 billion in the prior quarter.
- Across five years, Retained Earnings topped out at $1.7 billion in Q4 2025 and bottomed at -$36.0 million in Q3 2023.
- The 5-year median for Retained Earnings is $1.2 billion (2022), against an average of $871.5 million.
- Across the five-year window, Retained Earnings soared 6231.83% in 2022 and tumbled 106.86% in 2023, its largest moves.
- Year by year, Retained Earnings stood at -$23.2 million in 2021, then jumped by 6013.78% to $1.4 billion in 2022, then tumbled by 102.08% to -$28.5 million in 2023, then surged by 5377.7% to $1.5 billion in 2024, then gained by 12.39% to $1.7 billion in 2025.
- Per Business Quant, the three latest PBH Retained Earnings figures stand at $1.7 billion (Q4 2025), $1.6 billion (Q3 2025), and $1.6 billion (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 37.04 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 28.20 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.11 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 4.54 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 8.83 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -1.81 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 18.66 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 589.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -2.13 Bn |
| 10 | Prestige Consumer Healthcare | 2.34 Bn | 2.28 Bn | 157.37 Mn | 1.69 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.69 Bn |
| Sep 30, 2025 | 1.65 Bn |
| Jun 30, 2025 | 1.60 Bn |
| Mar 31, 2025 | 1.56 Bn |
| Dec 31, 2024 | 1.51 Bn |
| Sep 30, 2024 | 1.44 Bn |
| Jun 30, 2024 | 1.39 Bn |
| Mar 31, 2024 | 1.34 Bn |
| Dec 31, 2023 | -28.53 Mn |
| Sep 30, 2023 | -35.99 Mn |
| Jun 30, 2023 | -32.21 Mn |
| Mar 31, 2023 | -31.56 Mn |
| Dec 31, 2022 | 1.37 Bn |
| Sep 30, 2022 | 524.39 Mn |
| Jun 30, 2022 | 1.27 Bn |
| Mar 31, 2022 | 1.21 Bn |
| Dec 31, 2021 | -23.21 Mn |
| Sep 30, 2021 | -24.42 Mn |
| Jun 30, 2021 | 1.07 Bn |
| Mar 31, 2021 | -19.80 Mn |